Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve the audited Standalone Financial Results of the Company for the quarter and year on March 31, 2024 as per Regulation 33 of the Listing Regulation and Any other item of business as may be decided by the board of directors of the company. In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company vide letter dated March 27, 2024, the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company from Monday, April 01, 2024 till 48 hours declaration and publication of Audited Standalone Financial Results of the Company for the quarter and year on March 31, 2024.